Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Sustained Gq-Protein Signaling Disrupts Striatal Circuits via JNK.

Bellocchio L, Ruiz-Calvo A, Chiarlone A, Cabanas M, Resel E, Cazalets JR, Blázquez C, Cho YH, Galve-Roperh I, Guzmán M.

J Neurosci. 2016 Oct 12;36(41):10611-10624.

2.

MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.

Chiarlone A, Börner C, Martín-Gómez L, Jiménez-González A, García-Concejo A, García-Bermejo ML, Lorente M, Blázquez C, García-Taboada E, de Haro A, Martella E, Höllt V, Rodríguez R, Galve-Roperh I, Kraus J, Guzmán M.

Neuropharmacology. 2016 Sep;108:345-52. doi: 10.1016/j.neuropharm.2016.05.007. Epub 2016 May 11.

PMID:
27179908
3.

Chronic venous ulcer treatment with topical sevoflurane.

Imbernón A, Blázquez C, Puebla A, Churruca M, Lobato A, Martínez M, Aguilar A, Gallego MA.

Int Wound J. 2016 Oct;13(5):1060-2. doi: 10.1111/iwj.12474. Epub 2015 Jul 21. No abstract available.

PMID:
26198858
4.

Children at risk: A comparison of child pedestrian traffic collisions in Santiago, Chile, and Seoul, South Korea.

Blazquez C, Lee JS, Zegras C.

Traffic Inj Prev. 2016;17(3):304-12. doi: 10.1080/15389588.2015.1060555. Epub 2015 Jun 15.

PMID:
26075650
5.

The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.

Blázquez C, Chiarlone A, Bellocchio L, Resel E, Pruunsild P, García-Rincón D, Sendtner M, Timmusk T, Lutz B, Galve-Roperh I, Guzmán M.

Cell Death Differ. 2015 Oct;22(10):1618-29. doi: 10.1038/cdd.2015.11. Epub 2015 Feb 20.

6.

A restricted population of CB1 cannabinoid receptors with neuroprotective activity.

Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8257-62. doi: 10.1073/pnas.1400988111. Epub 2014 May 19.

7.

Feasibility and safety of hospital discharge 24 hours after laparoscopic radical prostatectomy.

Díaz FJ, Hernández V, de la Peña E, Blázquez C, Martín M, Llorente C.

Arch Esp Urol. 2013 Dec;66(10):931-8. English, Spanish.

PMID:
24369187
8.

Oncological outcomes in patients potentially eligible for active surveillance who underwent radical prostatectomy.

Blázquez C, Hernández V, de la Peña E, Díaz FJ, Martin MD, de la Morena JM, Llorente C.

Actas Urol Esp. 2013 Nov-Dec;37(10):603-7. doi: 10.1016/j.acuro.2013.02.015. Epub 2013 Jul 10.

PMID:
23850164
9.

Active surveillance in low-risk prostate cancer. Patient acceptance and results.

Hernández V, Blázquez C, de la Peña E, Pérez-Fernández E, Díaz FJ, Llorente C.

Actas Urol Esp. 2013 Oct;37(9):533-7. doi: 10.1016/j.acuro.2013.02.010. Epub 2013 Apr 22.

PMID:
23618513
10.

Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.

De La Peña E, Hernández V, Blázquez C, Martin MD, Díaz FJ, Capitán C, Alemany I, Llorente C.

BJU Int. 2013 Apr;111(4 Pt B):E196-201. doi: 10.1111/j.1464-410X.2012.11588.x. Epub 2012 Oct 26.

11.

A spatial and temporal analysis of child pedestrian crashes in Santiago, Chile.

Blazquez CA, Celis MS.

Accid Anal Prev. 2013 Jan;50:304-11. doi: 10.1016/j.aap.2012.05.001. Epub 2012 May 31.

PMID:
22658462
12.

A novel methodology for determining low-cost fine particulate matter street sweeping routes.

Blazquez CA, Beghelli A, Meneses VP.

J Air Waste Manag Assoc. 2012 Feb;62(2):242-51.

PMID:
22442940
13.

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C.

Eur Urol. 2011 Oct;60(4):734-9. doi: 10.1016/j.eururo.2011.05.043. Epub 2011 Jun 1.

PMID:
21658839
14.

External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer.

Hernández V, De La Peña E, Martin MD, Blázquez C, Diaz FJ, Llorente C.

World J Urol. 2011 Aug;29(4):409-14. doi: 10.1007/s00345-010-0635-2. Epub 2010 Dec 29.

PMID:
21190023
15.

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Blázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos MR, Resel E, Palazuelos J, Julien B, Salazar M, Börner C, Benito C, Carrasco C, Diez-Zaera M, Paoletti P, Díaz-Hernández M, Ruiz C, Sendtner M, Lucas JJ, de Yébenes JG, Marsicano G, Monory K, Lutz B, Romero J, Alberch J, Ginés S, Kraus J, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.

Brain. 2011 Jan;134(Pt 1):119-36. doi: 10.1093/brain/awq278. Epub 2010 Oct 7.

PMID:
20929960
16.

Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow.

Sanz C, Vázquez P, Blázquez C, Barrio PA, Alvarez Mdel M, Blázquez E.

Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E634-43. doi: 10.1152/ajpendo.00460.2009. Epub 2009 Dec 29.

PMID:
20040695
17.

Urban solid waste collection system using mathematical modelling and tools of geographic information systems.

Arribas CA, Blazquez CA, Lamas A.

Waste Manag Res. 2010 Apr;28(4):355-63. doi: 10.1177/0734242X09353435. Epub 2009 Nov 26.

PMID:
19942643
18.

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.

Barana A, Amorós I, Caballero R, Gómez R, Osuna L, Lillo MP, Blázquez C, Guzmán M, Delpón E, Tamargo J.

Cardiovasc Res. 2010 Jan 1;85(1):56-67. doi: 10.1093/cvr/cvp284.

PMID:
19689982
19.

Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.

Castro EC, Blazquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE, Graf N, Levy N, Lowe EJ, Manning JT Jr, Proytcheva MA, Senger C, Shayan K, Sterba J, Werner A, Surti U, Jaffe R.

Pediatr Dev Pathol. 2010 May-Jun;13(3):225-37. doi: 10.2350/09-03-0622-OA.1. Review.

PMID:
19642834
20.

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.

Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente M, Egia A, Vázquez P, Blázquez C, Torres S, García S, Nowak J, Fimia GM, Piacentini M, Cecconi F, Pandolfi PP, González-Feria L, Iovanna JL, Guzmán M, Boya P, Velasco G.

J Clin Invest. 2009 May;119(5):1359-72.

21.

Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.

Lorente M, Carracedo A, Torres S, Natali F, Egia A, Hernández-Tiedra S, Salazar M, Blázquez C, Guzmán M, Velasco G.

Glia. 2009 Oct;57(13):1374-85. doi: 10.1002/glia.20856.

PMID:
19229996
22.

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.

Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M.

Cancer Res. 2008 Mar 15;68(6):1945-52. doi: 10.1158/0008-5472.CAN-07-5176.

23.

Cannabinoids and gliomas.

Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M.

Mol Neurobiol. 2007 Aug;36(1):60-7. Epub 2007 Jun 28. Review.

PMID:
17952650
24.

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

Blázquez C, Carracedo A, Salazar M, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M.

Neuropharmacology. 2008 Jan;54(1):235-43. Epub 2007 Jul 1.

PMID:
17675107
25.

Cannabinoid receptors as novel targets for the treatment of melanoma.

Blázquez C, Carracedo A, Barrado L, Real PJ, Fernández-Luna JL, Velasco G, Malumbres M, Guzmán M.

FASEB J. 2006 Dec;20(14):2633-5. Epub 2006 Oct 25.

PMID:
17065222
26.

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I, Sánchez C, Velasco G, González-Feria L.

Br J Cancer. 2006 Jul 17;95(2):197-203. Epub 2006 Jun 27.

27.

Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.

Parody R, Martino R, Rovira M, Vazquez L, Vázquez MJ, de la Cámara R, Blazquez C, Fernández-Avilés F, Carreras E, Salavert M, Jarque I, Martín C, Martínez F, López J, Torres A, Sierra J, Sanz GF; Infectious/Non-infectious Complications Subcommittee of the Grupo Español de Trasplante Hematopoyético (GETH).

Biol Blood Marrow Transplant. 2006 Jul;12(7):734-48.

28.

The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.

Carracedo A, Lorente M, Egia A, Blázquez C, García S, Giroux V, Malicet C, Villuendas R, Gironella M, González-Feria L, Piris MA, Iovanna JL, Guzmán M, Velasco G.

Cancer Cell. 2006 Apr;9(4):301-12.

29.

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.

Kogan NM, Blázquez C, Alvarez L, Gallily R, Schlesinger M, Guzmán M, Mechoulam R.

Mol Pharmacol. 2006 Jul;70(1):51-9. Epub 2006 Mar 29.

30.

Functional characterization of human mesenchymal stem cells that maintain osteochondral fates.

Romero-Prado M, Blázquez C, Rodríguez-Navas C, Muñoz J, Guerrero I, Delgado-Baeza E, García-Ruiz JP.

J Cell Biochem. 2006 Aug 15;98(6):1457-70.

PMID:
16518860
31.

Phosphorylated KDR can be located in the nucleus of neoplastic cells.

Blazquez C, Cook N, Micklem K, Harris AL, Gatter KC, Pezzella F.

Cell Res. 2006 Jan;16(1):93-8.

32.

Modelling of sensory and instrumental texture parameters in processed cheese by near infrared reflectance spectroscopy.

Blazquez C, Downey G, O'Callaghan D, Howard V, Delahunty C, Sheehan E, Everard C, O'Donnell CP.

J Dairy Res. 2006 Feb;73(1):58-69.

PMID:
16433962
33.

Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study.

Zhang Y, Pillai G, Gatter K, Blázquez C, Turley H, Pezzella F, Watt SM.

Hum Pathol. 2005 Jul;36(7):797-805.

PMID:
16084950
34.

Cannabinoids and ceramide: two lipids acting hand-by-hand.

Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Haro A, Guzmán M.

Life Sci. 2005 Aug 19;77(14):1723-31. Review.

PMID:
15958274
35.

[Association of hemoglobinopathy and alpha thalassemia. Study of 45 patients].

Ataulfo González F, Blázquez C, Ropero P, Briceño O, Alaez C, Polo M, Benavente C, Mateo M, Peña A, Villegas A; Grupo de Eritropatología.

Med Clin (Barc). 2005 May 21;124(19):726-9. Spanish.

PMID:
15919031
36.

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML.

J Neurosci. 2005 Feb 23;25(8):1904-13.

37.

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M.

Cancer Res. 2004 Aug 15;64(16):5617-23.

38.

Hypothesis: cannabinoid therapy for the treatment of gliomas?

Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M.

Neuropharmacology. 2004 Sep;47(3):315-23. Review.

PMID:
15275820
39.

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Guzmán M, Lo Verme J, Fu J, Oveisi F, Blázquez C, Piomelli D.

J Biol Chem. 2004 Jul 2;279(27):27849-54. Epub 2004 Apr 26.

40.

Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus.

Fox SB, Turley H, Cheale M, Blázquez C, Roberts H, James N, Cook N, Harris A, Gatter K.

J Pathol. 2004 Mar;202(3):313-20.

PMID:
14991896
41.

Ketone body synthesis in the brain: possible neuroprotective effects.

Guzmán M, Blázquez C.

Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):287-92. Review.

PMID:
14769487
42.

Inhibition of tumor angiogenesis by cannabinoids.

Blázquez C, Casanova ML, Planas A, Gómez Del Pulgar T, Villanueva C, Fernández-Aceñero MJ, Aragonés J, Huffman JW, Jorcano JL, Guzmán M.

FASEB J. 2003 Mar;17(3):529-31. Epub 2003 Jan 2.

PMID:
12514108
43.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández-Aceñero MJ, Huffman JW, Jorcano JL, Guzmán M.

J Clin Invest. 2003 Jan;111(1):43-50.

44.

Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat.

Peralta C, Bartrons R, Serafin A, Blázquez C, Guzmán M, Prats N, Xaus C, Cutillas B, Gelpí E, Roselló-Catafau J.

Hepatology. 2001 Dec;34(6):1164-73.

PMID:
11732006
45.

High fat intake lowers hepatic fatty acid synthesis and raises fatty acid oxidation in aerobic muscle in Shetland ponies.

Geelen SN, Blázquez C, Geelen MJ, Sloet van Oldruitenborgh-Oosterbaan MM, Beynen AC.

Br J Nutr. 2001 Jul;86(1):31-6.

PMID:
11432762
46.

Is there an astrocyte-neuron ketone body shuttle?

Guzmán M, Blázquez C.

Trends Endocrinol Metab. 2001 May-Jun;12(4):169-73. Review.

PMID:
11295573
47.

The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes.

Blázquez C, Geelen MJ, Velasco G, Guzmán M.

FEBS Lett. 2001 Feb 2;489(2-3):149-53.

48.

De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase.

Blázquez C, Galve-Roperh I, Guzmán M.

FASEB J. 2000 Nov;14(14):2315-22.

PMID:
11053253
49.

The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes.

Blázquez C, Woods A, de Ceballos ML, Carling D, Guzmán M.

J Neurochem. 1999 Oct;73(4):1674-82.

50.

Supplemental Content

Loading ...
Support Center